OPKO Health

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OPKO Health and other ETFs, options, and stocks.

About OPK

OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. 

CEO
Phillip Frost
CEOPhillip Frost
Employees
2,997
Employees2,997
Headquarters
Miami, Florida
HeadquartersMiami, Florida
Founded
1991
Founded1991
Employees
2,997
Employees2,997

OPK Key Statistics

Market cap
1.03B
Market cap1.03B
Price-Earnings ratio
-5.64
Price-Earnings ratio-5.64
Dividend yield
Dividend yield
Average volume
2.19M
Average volume2.19M
High today
$1.40
High today$1.40
Low today
$1.34
Low today$1.34
Open price
$1.39
Open price$1.39
Volume
2.46M
Volume2.46M
52 Week high
$2.04
52 Week high$2.04
52 Week low
$1.11
52 Week low$1.11

Stock Snapshot

The current OPKO Health(OPK) stock price is $1.36, with a market capitalization of 1.03B. The stock trades at a price-to-earnings (P/E) ratio of -5.64.

On 2025-11-05, OPKO Health(OPK) stock moved within a range of $1.34 to $1.40. With shares now at $1.36, the stock is trading +1.5% above its intraday low and -2.9% below the session's peak.

Trading activity shows a volume of 2.46M, compared to an average daily volume of 2.19M.

The stock's 52-week range extends from a low of $1.11 to a high of $2.04.

The stock's 52-week range extends from a low of $1.11 to a high of $2.04.

OPK News

Simply Wall St 5d
OPKO Health Is Down 9.3% After Regeneron Collaboration and Asset Sale Announcement – Has the Bull Case Changed?

In the past week, OPKO Health announced a major research collaboration with Regeneron Pharmaceuticals to develop multispecific antibodies, while also reporting...

OPKO Health Is Down 9.3% After Regeneron Collaboration and Asset Sale Announcement – Has the Bull Case Changed?
TipRanks 5d
Opko Health’s CEO Makes Bold Move with Major Stock Purchase

New insider activity at Opko Health ( (OPK) ) has taken place on October 31, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...

Simply Wall St 6d
OPKO Health: Persistent Losses Worsen, Valuation Debate Intensifies Ahead of Earnings

OPKO Health (OPK) remains unprofitable, with losses increasing at an annual rate of 25% over the past five years. Despite facing headwinds on the bottom line, t...

OPKO Health: Persistent Losses Worsen, Valuation Debate Intensifies Ahead of Earnings

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

More OPK News

TipRanks 6d
Opko Health’s Strategic Moves Highlighted in Earnings Call

Opko Health ((OPK)) has held its Q3 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of TipRanks Prem...

People also own

Based on the portfolios of people who own OPK. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.